Gene · 56999
Papers1,498
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,498
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of autophagy‑modulating long non‑coding RNAs in tumor radioresistance (Review). | Oncol Rep | 2025 | 40849822 | PubTator, text mining | PubMed |
| lncRNA ADAMTS9-AS2/let-7a-5p axis regulates metabolic reprogramming by targeting HK2 in oral submucous fibrosis-associated oral squamous cell carcinoma. | Genes Dis | 2025 | 40831535 | PubTator, text mining | PubMed |
| Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer. | NPJ Precis Oncol | 2025 | 40825842 | PubTator, text mining | PubMed |
| Circulating microRNA profiles in early-stage osteoarthritis and rheumatoid arthritis. | Sci Rep | 2025 | 40730797 | PubTator, text mining | PubMed |
| Genetic Factors Associated with Intraocular Inflammation After Brolucizumab Administration in Patients with Exudative Age-Related Macular Degeneration. | Genes (Basel) | 2025 | 40725453 | PubTator, text mining | PubMed |
| An integrated approach for key gene selection and cancer phenotype classification: Improving diagnosis and prediction. | Comput Biol Med | 2025 | 40618695 | PubTator, text mining | PubMed |
| Letter to Editor: "The lncRNAs PART1 and ADAMTS9-AS2 act in an antithetic manner on AR signaling and induction of cellular senescence in prostate cancer cells". | Int J Surg | 2025 | 40503765 | PubTator, text mining | PubMed |
| Cleavage of the Meckel-Gruber syndrome protein TMEM67 by ADAMTS9 uncouples Wnt signaling and ciliogenesis. | Nat Commun | 2025 | 40436881 | PubTator, text mining | PubMed |
| LncRNA interactomes and co-methylation in breast cancer regulation. | Biomol Biomed | 2025 | 40350996 | PubTator, text mining | PubMed |
| Retraction: Tocilizumab inhibits neuronal cell apoptosis and activates STAT3 in cerebral infarction rat model. | Biomol Biomed | 2025 | 40340652 | PubTator, text mining | PubMed |
| In utero exposure to synthetic sex hormones and their multigenerational impact on neurodevelopmental disorders: Endocrine disruptors as neuroendocrine disruptors. | J Neurol Sci | 2025 | 40187226 | PubTator, text mining | PubMed |
| Advance in candidate genes in mandibular retrognathism: A systematic review. | Arch Oral Biol | 2025 | 40132276 | PubTator, text mining | PubMed |
| IL-1β stimulates ADAMTS9 expression and contributes to preterm prelabor rupture of membranes. | Cell Commun Signal | 2025 | 40057799 | PubTator, text mining | PubMed |
| SARS-CoV-2 enhances complement-mediated endothelial injury via the suppression of membrane complement regulatory proteins. | Emerg Microbes Infect | 2025 | 39945674 | PubTator, text mining | PubMed |
| Assessment of Methylation in Selected ADAMTS Family Genes in Non-Small-Cell Lung Cancer. | Int J Mol Sci | 2025 | 39940703 | PubTator, text mining | PubMed |
| The Dual Role of ADAMTS9-AS1 in Various Human Cancers: Molecular Pathogenesis and Clinical Implications. | Anticancer Agents Med Chem | 2025 | 39773057 | PubTator, text mining | PubMed |
| Ferrostatin-1 improves acute sepsis-induced cardiomyopathy via inhibiting neutrophil infiltration through impaired chemokine axis. | Front Cell Dev Biol | 2024 | 39726718 | PubTator, text mining | PubMed |
| Targeting LncRNA ADAMTS9-AS1 is a Promising Therapeutic Strategy to Inhibit the Progression of Bladder Cancer. | Discov Med | 2024 | 39726319 | PubTator, text mining | PubMed |
| Unveiling four axes ADAMTS9-AS2|MEG3/hsa-miR-150/PRKCA|MMP14 within prostate cancer through establishment of the ceRNA network. | Pathol Res Pract | 2024 | 39341147 | PubTator, text mining | PubMed |
| Astrocytes originated from neural stem cells drive the regenerative remodeling of pathologic CSPGs in spinal cord injury. | Stem Cell Reports | 2024 | 39303705 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/56999/papers?page=2